A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
- 1 November 1987
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 84 (22) , 7967-7971
- https://doi.org/10.1073/pnas.84.22.7967
Abstract
We recently isolated, from culture fluids of Staphylococcus aureus, a chemotactic peptide that comprised equimolar quantities of methionine, leucine, phenylalanine, and isoleucine. It interacted with the formylmethionyl peptide receptor of human leukocytes and had considerably higher potency and efficacy than the widely studied tripeptide agonist fMet-Leu-Phe. On the assumption that the attractant was a formylmethionyl tetrapeptide, we synthesized the six possible sequences and tested the products for chemotactic potency and efficacy, as well as their capacity to inhibit binding of fluorescein isothiocyanate-labeled fMet-Leu-Phe-Lys to human monocytes. The concentrations required for inhibition of fluorescein-labeled fMet-Leu-Phe-Lys binding by the six peptides covered three orders of magnitude. Chemotactic potency (concentration that caused 50% of the maximum chemotactic response) ranged from 3.1 X 10(-11) M to 6.4 X 10(-10) M; efficacy (percentage of monocytes migrating at optimal attractant concentration) ranged from 41% to 66%. When the six synthetic tetrapeptides were ranked for chemotactic efficacy, they paired according to the position of phenylalanine. The average percentage migration was 66% for the two peptides with phenylalanine in position 3, 51% for phenylalanine in position 4, and 41% for phenylalanine in position 2. Since the published value for the percentage of human monocytes with detectable formyl peptide receptors is 60%, it is apparent that the two tetrapeptides with phenylalanine in position 3 (fMet-Ile-Phe-Leu and fMet-Leu-Phe-Ile) are full chemotactic agonists, which are capable of inducing migration of all the receptor-bearing cells. This is in contrast to the tripeptide fMet-Leu-Phe, which induces migration of only 50% of monocytes with receptors (efficacy of 33%). Since the chemotactic efficacy of the six tetrapeptides covers a wide range, the series may be useful to investigate signals that lead to directed movement after occupancy of receptors by chemoattractants.This publication has 17 references indexed in Scilit:
- Staphylococcus aureus-Derived Chemoattractant Activity for Human MonocytesJournal of Leukocyte Biology, 1986
- Purification and characterization of neutrophil chemotactic factors of Streptococcus sanguisBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Differences in superoxide production by nonmigrating and migrating human monocyte subpopulationsBiochemical and Biophysical Research Communications, 1982
- Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophilsBiochemistry, 1982
- EFFECTS OF CELL CONCENTRATION ON CHEMOTACTIC RESPONSIVENESS OF MOUSE RESIDENT PERITONEAL-MACROPHAGES1981
- Further studies on the structural requirements for synthetic peptide chemoattractantsBiochemistry, 1980
- Rapid quantitation of neutrophil chemotaxis: Use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assemblyJournal of Immunological Methods, 1980
- Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils.Journal of Biological Chemistry, 1979
- Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.Journal of Clinical Investigation, 1978
- N-formylmethionyl peptides as chemoattractants for leucocytes.Proceedings of the National Academy of Sciences, 1975